Global Invasive Candidiasis Treatment Drug Market Growth (Status and Outlook) 2023-2029
The global Invasive Candidiasis Treatment Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Invasive Candidiasis Treatment Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Invasive Candidiasis Treatment Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Invasive Candidiasis Treatment Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Invasive Candidiasis Treatment Drug players cover GlaxoSmithKline, Merck & Co., Inc, Pfizer Inc, Cidara Therapeutics, Inc, Astellas Pharma Inc, Gilead Sciences, Inc, Novo Nordisk A/S (Xellia Pharmaceuticals), Biosergen AB and Matinas BioPharma Holdings, Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Invasive Candidiasis Treatment Drug Industry Forecast” looks at past sales and reviews total world Invasive Candidiasis Treatment Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Invasive Candidiasis Treatment Drug sales for 2023 through 2029. With Invasive Candidiasis Treatment Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Invasive Candidiasis Treatment Drug industry.
This Insight Report provides a comprehensive analysis of the global Invasive Candidiasis Treatment Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Invasive Candidiasis Treatment Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Invasive Candidiasis Treatment Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Invasive Candidiasis Treatment Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Invasive Candidiasis Treatment Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Invasive Candidiasis Treatment Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Azoles Drug
Echinocandins Drug
Allylamines Drug
Polyenes Drug
Others
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GlaxoSmithKline
Merck & Co., Inc
Pfizer Inc
Cidara Therapeutics, Inc
Astellas Pharma Inc
Gilead Sciences, Inc
Novo Nordisk A/S (Xellia Pharmaceuticals)
Biosergen AB
Matinas BioPharma Holdings, Inc
Pulmocide Ltd
F2G Ltd
Please note: The report will take approximately 2 business days to prepare and deliver.
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Invasive Candidiasis Treatment Drug Market Size 2018-2029
- 2.1.2 Invasive Candidiasis Treatment Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Invasive Candidiasis Treatment Drug Segment by Type
- 2.2.1 Azoles Drug
- 2.2.2 Echinocandins Drug
- 2.2.3 Allylamines Drug
- 2.2.4 Polyenes Drug
- 2.2.5 Others
- 2.3 Invasive Candidiasis Treatment Drug Market Size by Type
- 2.3.1 Invasive Candidiasis Treatment Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2018-2023)
- 2.4 Invasive Candidiasis Treatment Drug Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Others
- 2.5 Invasive Candidiasis Treatment Drug Market Size by Application
- 2.5.1 Invasive Candidiasis Treatment Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Invasive Candidiasis Treatment Drug Market Size Market Share by Application (2018-2023)
- 3 Invasive Candidiasis Treatment Drug Market Size by Player
- 3.1 Invasive Candidiasis Treatment Drug Market Size Market Share by Players
- 3.1.1 Global Invasive Candidiasis Treatment Drug Revenue by Players (2018-2023)
- 3.1.2 Global Invasive Candidiasis Treatment Drug Revenue Market Share by Players (2018-2023)
- 3.2 Global Invasive Candidiasis Treatment Drug Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Invasive Candidiasis Treatment Drug by Regions
- 4.1 Invasive Candidiasis Treatment Drug Market Size by Regions (2018-2023)
- 4.2 Americas Invasive Candidiasis Treatment Drug Market Size Growth (2018-2023)
- 4.3 APAC Invasive Candidiasis Treatment Drug Market Size Growth (2018-2023)
- 4.4 Europe Invasive Candidiasis Treatment Drug Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size Growth (2018-2023)
- 5 Americas
- 5.1 Americas Invasive Candidiasis Treatment Drug Market Size by Country (2018-2023)
- 5.2 Americas Invasive Candidiasis Treatment Drug Market Size by Type (2018-2023)
- 5.3 Americas Invasive Candidiasis Treatment Drug Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Invasive Candidiasis Treatment Drug Market Size by Region (2018-2023)
- 6.2 APAC Invasive Candidiasis Treatment Drug Market Size by Type (2018-2023)
- 6.3 APAC Invasive Candidiasis Treatment Drug Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Invasive Candidiasis Treatment Drug by Country (2018-2023)
- 7.2 Europe Invasive Candidiasis Treatment Drug Market Size by Type (2018-2023)
- 7.3 Europe Invasive Candidiasis Treatment Drug Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Invasive Candidiasis Treatment Drug by Region (2018-2023)
- 8.2 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Invasive Candidiasis Treatment Drug Market Forecast
- 10.1 Global Invasive Candidiasis Treatment Drug Forecast by Regions (2024-2029)
- 10.1.1 Global Invasive Candidiasis Treatment Drug Forecast by Regions (2024-2029)
- 10.1.2 Americas Invasive Candidiasis Treatment Drug Forecast
- 10.1.3 APAC Invasive Candidiasis Treatment Drug Forecast
- 10.1.4 Europe Invasive Candidiasis Treatment Drug Forecast
- 10.1.5 Middle East & Africa Invasive Candidiasis Treatment Drug Forecast
- 10.2 Americas Invasive Candidiasis Treatment Drug Forecast by Country (2024-2029)
- 10.2.1 United States Invasive Candidiasis Treatment Drug Market Forecast
- 10.2.2 Canada Invasive Candidiasis Treatment Drug Market Forecast
- 10.2.3 Mexico Invasive Candidiasis Treatment Drug Market Forecast
- 10.2.4 Brazil Invasive Candidiasis Treatment Drug Market Forecast
- 10.3 APAC Invasive Candidiasis Treatment Drug Forecast by Region (2024-2029)
- 10.3.1 China Invasive Candidiasis Treatment Drug Market Forecast
- 10.3.2 Japan Invasive Candidiasis Treatment Drug Market Forecast
- 10.3.3 Korea Invasive Candidiasis Treatment Drug Market Forecast
- 10.3.4 Southeast Asia Invasive Candidiasis Treatment Drug Market Forecast
- 10.3.5 India Invasive Candidiasis Treatment Drug Market Forecast
- 10.3.6 Australia Invasive Candidiasis Treatment Drug Market Forecast
- 10.4 Europe Invasive Candidiasis Treatment Drug Forecast by Country (2024-2029)
- 10.4.1 Germany Invasive Candidiasis Treatment Drug Market Forecast
- 10.4.2 France Invasive Candidiasis Treatment Drug Market Forecast
- 10.4.3 UK Invasive Candidiasis Treatment Drug Market Forecast
- 10.4.4 Italy Invasive Candidiasis Treatment Drug Market Forecast
- 10.4.5 Russia Invasive Candidiasis Treatment Drug Market Forecast
- 10.5 Middle East & Africa Invasive Candidiasis Treatment Drug Forecast by Region (2024-2029)
- 10.5.1 Egypt Invasive Candidiasis Treatment Drug Market Forecast
- 10.5.2 South Africa Invasive Candidiasis Treatment Drug Market Forecast
- 10.5.3 Israel Invasive Candidiasis Treatment Drug Market Forecast
- 10.5.4 Turkey Invasive Candidiasis Treatment Drug Market Forecast
- 10.5.5 GCC Countries Invasive Candidiasis Treatment Drug Market Forecast
- 10.6 Global Invasive Candidiasis Treatment Drug Forecast by Type (2024-2029)
- 10.7 Global Invasive Candidiasis Treatment Drug Forecast by Application (2024-2029)
- 11 Key Players Analysis
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Company Information
- 11.1.2 GlaxoSmithKline Invasive Candidiasis Treatment Drug Product Offered
- 11.1.3 GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 GlaxoSmithKline Main Business Overview
- 11.1.5 GlaxoSmithKline Latest Developments
- 11.2 Merck & Co., Inc
- 11.2.1 Merck & Co., Inc Company Information
- 11.2.2 Merck & Co., Inc Invasive Candidiasis Treatment Drug Product Offered
- 11.2.3 Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 Merck & Co., Inc Main Business Overview
- 11.2.5 Merck & Co., Inc Latest Developments
- 11.3 Pfizer Inc
- 11.3.1 Pfizer Inc Company Information
- 11.3.2 Pfizer Inc Invasive Candidiasis Treatment Drug Product Offered
- 11.3.3 Pfizer Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 Pfizer Inc Main Business Overview
- 11.3.5 Pfizer Inc Latest Developments
- 11.4 Cidara Therapeutics, Inc
- 11.4.1 Cidara Therapeutics, Inc Company Information
- 11.4.2 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product Offered
- 11.4.3 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 Cidara Therapeutics, Inc Main Business Overview
- 11.4.5 Cidara Therapeutics, Inc Latest Developments
- 11.5 Astellas Pharma Inc
- 11.5.1 Astellas Pharma Inc Company Information
- 11.5.2 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product Offered
- 11.5.3 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 Astellas Pharma Inc Main Business Overview
- 11.5.5 Astellas Pharma Inc Latest Developments
- 11.6 Gilead Sciences, Inc
- 11.6.1 Gilead Sciences, Inc Company Information
- 11.6.2 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product Offered
- 11.6.3 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Gilead Sciences, Inc Main Business Overview
- 11.6.5 Gilead Sciences, Inc Latest Developments
- 11.7 Novo Nordisk A/S (Xellia Pharmaceuticals)
- 11.7.1 Novo Nordisk A/S (Xellia Pharmaceuticals) Company Information
- 11.7.2 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product Offered
- 11.7.3 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 Novo Nordisk A/S (Xellia Pharmaceuticals) Main Business Overview
- 11.7.5 Novo Nordisk A/S (Xellia Pharmaceuticals) Latest Developments
- 11.8 Biosergen AB
- 11.8.1 Biosergen AB Company Information
- 11.8.2 Biosergen AB Invasive Candidiasis Treatment Drug Product Offered
- 11.8.3 Biosergen AB Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 Biosergen AB Main Business Overview
- 11.8.5 Biosergen AB Latest Developments
- 11.9 Matinas BioPharma Holdings, Inc
- 11.9.1 Matinas BioPharma Holdings, Inc Company Information
- 11.9.2 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product Offered
- 11.9.3 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 Matinas BioPharma Holdings, Inc Main Business Overview
- 11.9.5 Matinas BioPharma Holdings, Inc Latest Developments
- 11.10 Pulmocide Ltd
- 11.10.1 Pulmocide Ltd Company Information
- 11.10.2 Pulmocide Ltd Invasive Candidiasis Treatment Drug Product Offered
- 11.10.3 Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 Pulmocide Ltd Main Business Overview
- 11.10.5 Pulmocide Ltd Latest Developments
- 11.11 F2G Ltd
- 11.11.1 F2G Ltd Company Information
- 11.11.2 F2G Ltd Invasive Candidiasis Treatment Drug Product Offered
- 11.11.3 F2G Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 F2G Ltd Main Business Overview
- 11.11.5 F2G Ltd Latest Developments
- 12 Research Findings and Conclusion
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook